{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:59:44Z","timestamp":1793109584458,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.chom.2023.10.001","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T15:36:01Z","timestamp":1699457761000},"page":"1921-1929.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-7031","authenticated-orcid":false,"given":"Ville N.","family":"Pimenoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Louvanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Lagheden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"S\u00f6derlund-Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Lehtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2023.10.001_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1098\/rspb.1995.0164","article-title":"Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework","volume":"261","author":"McLean","year":"1995","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.chom.2023.10.001_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/infdis\/jiy545","article-title":"Long-term antibody response to human papillomavirus vaccines: up to 12 years of follow-up in the Finnish maternity cohort","volume":"219","author":"Artemchuk","year":"2019","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.001_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100401","article-title":"Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four Nordic countries","volume":"23","author":"Kjaer","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.chom.2023.10.001_bib4","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/infdis\/jiaa617","article-title":"Sustained cross-reactive antibody responses after human papillomavirus vaccinations: up to 12 years follow-up in the Finnish maternity cohort","volume":"223","author":"Kann","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.001_bib5","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S1473-3099(20)30873-2","article-title":"Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials","volume":"21","author":"Mariz","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.001_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.001_bib7","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/ijc.31618","article-title":"Gender-neutral vaccination provides improved control of human papillomavirus types 18\/31\/33\/35 through herd immunity: results of a community randomized trial (III)","volume":"143","author":"Lehtinen","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2023.10.001_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/14760584.2019.1568876","article-title":"Eradication of human papillomavirus and elimination of HPV-related diseases - Scientific basis for global public health policies","volume":"18","author":"Lehtinen","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.chom.2023.10.001_bib9","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/infdis\/jiaa099","article-title":"Vaccination with moderate coverage eradicates oncogenic human papillomaviruses if a gender-neutral strategy is applied","volume":"222","author":"V\u00e4nsk\u00e4","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.001_bib10","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/ijc.31281","article-title":"Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females\u2013post-hoc analysis of a community-randomized clinical trial (II)","volume":"142","author":"Gray","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2023.10.001_bib11","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1002\/ijc.33169","article-title":"Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverage","volume":"147","author":"Gray","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2023.10.001_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ijc.34231","article-title":"HPV type-specific trends in cervical precancers in the United States, 2008 to 2016","volume":"152","author":"Gargano","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2023.10.001_bib13","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3201\/eid2210.160675","article-title":"Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes","volume":"22","author":"Mesher","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.001_bib14","series-title":"Matapopulation Ecology","author":"Hanski","year":"1999"},{"key":"10.1016\/j.chom.2023.10.001_bib15","series-title":"Evolution in Health and Disease","author":"Stearns","year":"2007"},{"key":"10.1016\/j.chom.2023.10.001_bib16","series-title":"Infectious Diseases of Humans: Epidemiology and Control","author":"Anderson","year":"1991"},{"key":"10.1016\/j.chom.2023.10.001_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1098\/rsif.2007.0229","article-title":"Patterns of antigenic diversity and the mechanisms that maintain them","volume":"4","author":"Lipsitch","year":"2007","journal-title":"J.\u00a0R. Soc. Interface"},{"key":"10.1016\/j.chom.2023.10.001_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41576-018-0055-5","article-title":"The phylogenomics of evolving virus virulence","volume":"19","author":"Geoghegan","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.chom.2023.10.001_bib19","first-page":"1","article-title":"Graphical independence networks with the grain package for R","volume":"46","author":"H\u00f8jsgaard","year":"2012","journal-title":"J.\u00a0Stat. Softw."},{"key":"10.1016\/j.chom.2023.10.001_bib20","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jcv.2015.11.020","article-title":"Cervical cancer screening of HPV vaccinated populations: cytology, molecular testing, both or none","volume":"76","author":"El-Zein","year":"2016","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.chom.2023.10.001_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11017-010-9167-4","article-title":"Research traditions and evolutionary explanations in medicine","volume":"32","author":"M\u00e9thot","year":"2011","journal-title":"Theor. Med. Bioeth."},{"key":"10.1016\/j.chom.2023.10.001_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.32802","article-title":"Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women","volume":"147","author":"Louvanto","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2023.10.001_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003588","article-title":"Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: a cross-sectional cohort analysis following a cluster randomized trial","volume":"18","author":"Gray","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.chom.2023.10.001_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/ijc.34286","article-title":"Assessing the risk of cervical neoplasia in the post-HPV vaccination era","volume":"152","author":"Lehtinen","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2023.10.001_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.2041-210X.2012.00190.x","article-title":"mvabund - an R package for model-based analysis of multivariate abundance data","volume":"3","author":"Wang","year":"2012","journal-title":"Methods Ecol. Evol."},{"key":"10.1016\/j.chom.2023.10.001_bib26","doi-asserted-by":"crossref","first-page":"C4","DOI":"10.1016\/j.vaccine.2008.02.007","article-title":"Evidences of parasite evolution after vaccination","volume":"26","author":"Gandon","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2023.10.001_bib27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103154118","article-title":"SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma","volume":"118","author":"Andreano","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2023.10.001_bib28","article-title":"Could the human papillomavirus vaccines drive virulence evolution?","volume":"282","author":"Murall","year":"2015","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.chom.2023.10.001_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.micro.62.081307.162912","article-title":"Evolutionary history and phylogeography of human viruses","volume":"62","author":"Holmes","year":"2008","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.chom.2023.10.001_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19273-z","article-title":"Intraspecific host variation plays a key role in virus community assembly","volume":"11","author":"Sallinen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2023.10.001_bib31","series-title":"The Princeton Guide to Ecology","first-page":"3","article-title":"Ecological niche","author":"Schoener","year":"2009"},{"key":"10.1016\/j.chom.2023.10.001_bib32","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ijc.32189","article-title":"Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: post-hoc analysis of a community randomized clinical trial up to nine years after vaccination (IV)","volume":"145","author":"Gray","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2023.10.001_bib33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/infdis\/jiaa032","article-title":"Human papillomavirus genotype replacement: still too early to tell?","volume":"224","author":"Man","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2023.10.001_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01636-1","article-title":"Enhancing diversity analysis by repeatedly rarefying next generation sequencing data describing microbial communities","volume":"11","author":"Cameron","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2023.10.001_bib35","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2023.10.001_bib36","series-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","year":"2020"},{"key":"10.1016\/j.chom.2023.10.001_bib37","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.50.2101154","article-title":"Moral dilemma(s) in human papillomavirus vaccination\u00a0\u2013 revisiting the role of the herd effect","volume":"26","author":"Lehtinen","year":"2021","journal-title":"Euro Surveill."},{"key":"10.1016\/j.chom.2023.10.001_bib38","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ijc.29019","article-title":"Judging the carcinogenicity of rare human papillomavirus types","volume":"136","author":"Combes","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2023.10.001_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1158\/1055-9965.EPI-12-1003","article-title":"High-throughput monitoring of human papillomavirus type distribution","volume":"22","author":"S\u00f6derlund-Strand","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.chom.2023.10.001_bib40","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/ijc.22131","article-title":"Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s","volume":"119","author":"Lehtinen","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2023.10.001_bib41","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.vaccine.2014.12.019","article-title":"Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial","volume":"33","author":"Lehtinen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2023.10.001_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02407","article-title":"Rarefaction, alpha diversity, and statistics","volume":"10","author":"Willis","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.chom.2023.10.001_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/j.1538-7305.1948.tb01338.x","article-title":"A mathematical theory of communication","volume":"27","author":"Shannon","year":"1948","journal-title":"Bell Syst. Tech. J."},{"key":"10.1016\/j.chom.2023.10.001_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/163688a0","article-title":"Measurement of diversity","volume":"163","author":"Simpson","year":"1949","journal-title":"Nature"},{"key":"10.1016\/j.chom.2023.10.001_bib45","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/ijc.31964","article-title":"Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: results from a worldwide cross-sectional study","volume":"144","author":"Pimenoff","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chom.2023.10.001_bib46","series-title":"Probabilistic Graphical Models: Principles and Techniques","author":"Koller","year":"2009"}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312823003992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312823003992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T01:49:28Z","timestamp":1720057768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312823003992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1931312823003992"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2023.10.001","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2023.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}